- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 4.95M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $40.35M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $40.72M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $900K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $500K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $133.93M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $131.3M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $227.52M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $231.04M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $98.96M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $108.06M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $421.53M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $430.25M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $29.94M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $18.73M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 4.9M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $263K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $6.87M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $51.35M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $56.1M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $13.21M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $8.77M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.05M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.88M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $50.07M |
| Revenue | Q1 2025 · Mar 31, 2024 | $86.8M |